Spinal Cord Stimulation for Failed Back Surgery Syndrome
When persistent pain continues even after spine surgery
Back surgery is often performed to relieve nerve compression, spinal instability, or structural causes of pain. Yet some patients continue to experience pain even after technically successful surgery. This condition is commonly described as Failed Back Surgery Syndrome (FBSS). In simple terms, it means that the patient still has significant pain after one or more spinal operations, despite treatment that was expected to help.
For many of these patients, the pain is not purely mechanical. It may be neuropathic, persistent, radiating, burning, electric, or associated with altered pain processing in the nervous system. In such situations, repeating surgery is not always the best answer. When medicines, rehabilitation, injections, and other conservative measures do not provide meaningful relief, Spinal Cord Stimulation (SCS) becomes an important treatment option.
What is Failed Back Surgery Syndrome?
Failed Back Surgery Syndrome refers to persistent or recurrent pain after spinal surgery, especially when the pain continues to interfere with daily life, sleep, mobility, and quality of life.
This pain may involve:
- Persistent low back pain
- Radiating leg pain
- Neuropathic pain after surgery
- Burning, tingling, or electric shock–like pain
- Pain that worsens despite medication
- Functional limitation even after surgery
FBSS does not always mean the surgery was “wrong.” In many patients, pain persists because of nerve damage, epidural scarring, altered pain signaling, recurrent pathology, mixed pain mechanisms, or central sensitization.
Why SCS is considered in Failed Back Surgery Syndrome
When pain continues after surgery, the next treatment step should not automatically be another operation. In appropriately selected patients, Spinal Cord Stimulation can reduce pain, improve function, and decrease reliance on medications.
SCS is especially considered when:
- Pain has been present for more than 6 months
- Neuropathic or radicular pain is predominant
- Conservative treatment has failed
- The patient is not an ideal candidate for further corrective surgery
- There is no major uncontrolled psychiatric issue
- The patient understands the therapy and has realistic expectations
What is Spinal Cord Stimulation?
Spinal Cord Stimulation is an advanced pain treatment in which thin electrodes are placed in the epidural space near the spinal cord. These leads deliver controlled electrical impulses that modify how pain signals are processed before they reach the brain.
It is a form of neuromodulation. It does not remove the original disease, but it can significantly reduce pain perception and improve daily functioning.
How does SCS work?
The classical explanation is based on the gate control concept of pain. According to this principle, stimulation of large sensory fibers can help reduce transmission of pain carried by smaller pain fibers at the spinal cord level.
In addition to this, SCS also appears to work by:
- Modulating abnormal pain signaling in the dorsal horn
- Reducing hyperexcitability of pain pathways
- Influencing neurotransmitter activity
- Altering pain processing at spinal and supraspinal levels
- Improving function even when complete pain elimination is not possible
Who may benefit from SCS?
SCS is most useful in carefully selected patients. It is not meant for every pain patient.
Common situations where SCS may be considered include:
- Failed Back Surgery Syndrome
- Complex regional pain syndrome
- Painful diabetic neuropathy
- Chronic neuropathic limb pain
- Ischemic pain of the extremities
- Refractory anginal pain in selected cases
Among these, Failed Back Surgery Syndrome remains one of the most important and most established indications.
What type of pain responds best?
SCS generally works better when the pain is:
- Neuropathic rather than purely nociceptive
- Radiating or nerve-related
- Chronic and treatment-resistant
- Function-limiting
- Present despite proper medication and rehabilitation
Patients with severe axial mechanical pain alone may not get the same degree of benefit as those with a stronger neuropathic component.
Patient selection before SCS
Proper patient selection is one of the most important steps in successful SCS therapy.
A good candidate usually has:
- Chronic pain for more than 6 months
- Predominantly neuropathic pain
- Failure of conservative treatment
- No major active infection
- No major untreated psychological or psychiatric problem
- Ability to understand and participate in trial testing
- Realistic goals, such as pain reduction and improved activity, not necessarily total cure
Psychological screening is often valuable because it helps reduce the risk of failed implantation.
Types of SCS leads
There are two broad types of electrodes used in SCS:
1. Percutaneous leads
These are inserted through needles under fluoroscopic guidance. They are commonly used by pain physicians and are especially useful for trial stimulation.
2. Paddle leads
These are placed surgically, usually by a spine surgeon or neurosurgeon, and generally require laminotomy or laminectomy.
Both systems are connected to a power source, commonly called an implantable pulse generator (IPG).
Components of an SCS system
A typical SCS system includes:
- Epidural stimulation lead or leads
- Extension wire if required
- Implantable pulse generator
- External programmer or remote control
- Charger in rechargeable systems
The patient can usually control certain settings such as switching programs on or off and adjusting intensity within prescribed limits.
Steps of Spinal Cord Stimulation Implantation
Step 1: Clinical evaluation and patient selection
The process starts with detailed evaluation of the pain pattern, previous treatments, imaging, neurological findings, medication history, and functional limitation. At this stage, the physician determines whether the pain is suitable for neuromodulation.
Step 2: Psychological assessment
A psychological or psychiatric assessment may be performed to identify factors that could reduce the chance of success, such as unrealistic expectations, severe untreated depression, major anxiety, or maladaptive pain behavior.
Step 3: Planning the target level
The lead placement is planned according to the patient’s pain distribution. The target spinal level depends on whether the pain is in the back, leg, foot, upper limb, neck, or abdomen.
Step 4: Pre-procedure preparation
Before the procedure:
- Informed consent is taken
- Intravenous access is secured
- Basic monitoring is applied
- Antibiotic prophylaxis is given when appropriate
- Resuscitation readiness is ensured
- The patient is positioned prone
- Strict aseptic precautions are maintained
Step 5: Fluoroscopic localization
Fluoroscopy is used to identify the correct interlaminar entry point and guide safe placement of the epidural needle and lead.
Step 6: Epidural needle insertion
A special epidural needle is introduced through a paramedian or near-midline skin entry point, usually a few segments below the intended final lead position. The needle entry point is 1-2 segments below the epidural space entry. The needle is advanced carefully under fluoroscopic guidance into the epidural space.
Step 7: Confirmation of epidural space entry
Loss of resistance and imaging help confirm entry into the epidural space. A lateral fluoroscopic view is important to assess depth and ensure safe positioning.
Step 8: Lead advancement in the posterior epidural space
The stimulation lead is threaded through the needle and advanced upward in the posterior epidural space toward the planned spinal level. Proper lead orientation is important so that stimulation covers the painful anatomical region.
Step 9: Intra-procedural testing
The lead is tested to determine whether stimulation covers the patient’s painful area adequately. This helps confirm that the lead is at the right level and position.
Step 10: Securing the lead
Once satisfactory coverage is obtained, the lead is secured to reduce the risk of migration. Temporary external connection is maintained during the trial phase.
Step 11: Trial stimulation period
A trial is performed before permanent implantation. The trial usually lasts a few days. During this period, the patient assesses how much pain relief and functional improvement the stimulation provides.
A successful trial generally means:
- At least 50% pain relief
- Better function
- Improved sleep or activity
- Reduced need for pain medication
- Patient satisfaction with the therapy
Step 12: Permanent implantation
If the trial is successful, the patient proceeds to permanent implantation. The internal pulse generator is implanted subcutaneously, often in the lower abdominal wall or upper gluteal region, and connected to the implanted lead system.
Step 13: Programming and follow-up
After implantation, the device is programmed according to the patient’s response. Parameters such as frequency, amplitude, pulse width, and electrode combinations are adjusted to optimize pain relief.
Follow-up is essential for:
- Program refinement
- Battery management
- Monitoring complications
- Assessing pain and function over time
What is the trial period in SCS?
The trial period is one of the most important parts of SCS therapy. It helps determine whether the patient is likely to benefit before committing to permanent implantation.
The patient goes home with temporary external stimulation and monitors:
- Pain reduction
- Functional improvement
- Sleep improvement
- Comfort with the stimulation
- Ability to perform daily activities better
This stage helps avoid unnecessary permanent implantation in non-responders.
What defines a successful SCS outcome?
Success is not defined only by pain score reduction. A good result often includes:
- At least 50% pain relief
- Better walking, sitting, or sleeping
- Return to work or improved routine activity
- Lower medication burden
- Better quality of life
- Improved confidence and independence
Benefits of Spinal Cord Stimulation
Potential benefits of SCS include:
- Reduction in chronic neuropathic pain
- Improvement in daily function
- Reduction in analgesic consumption
- Reversible and adjustable therapy
- Trial before permanent implantation
- Option for patients who have exhausted many other treatments
Possible complications of SCS
Like any invasive pain procedure, SCS has risks. Complications may range from minor to serious.
These may include:
- Infection
- Lead migration
- Lead breakage
- Dural puncture
- Bleeding
- Post-procedure pain
- Device malfunction
- Neurological injury
- Inadequate pain coverage
- Need for revision surgery
This is why meticulous technique, proper patient selection, and structured follow-up are essential.
FAQ: Spinal Cord Stimulation for Failed Back Surgery Syndrome
What is the main role of SCS in failed back surgery syndrome?
SCS is used to reduce persistent pain after spine surgery, especially when neuropathic or radiating pain continues despite medicines, therapy, and other treatments.
Does SCS mean my previous back surgery failed?
Not necessarily. It means pain has persisted or returned after surgery. This may happen even after technically successful surgery because pain can continue due to nerve injury, scarring, altered pain signaling, or mixed pain mechanisms.
Is SCS a cure for FBSS?
No. SCS is not a cure. It is a pain modulation treatment designed to reduce pain and improve function.
Who is the ideal candidate for SCS?
The best candidates are patients with chronic neuropathic pain, especially after spine surgery, who have failed conservative treatment and do not have major untreated psychiatric issues or active infection.
Is there a trial before permanent implantation?
Yes. A temporary trial is usually done first. This is one of the greatest strengths of SCS because it allows testing before full implantation.
How much pain relief should I expect?
A commonly used benchmark for success is at least 50% pain relief, along with improved daily activity and reduced medication need.
Where are the leads placed?
The leads are placed in the epidural space near the spinal cord, not inside the spinal cord.
Is the procedure done under fluoroscopy?
Yes. Fluoroscopy is typically used to guide needle entry, epidural placement, and lead advancement.
Can I control the device after implantation?
Yes. Most modern systems allow the patient to switch programs, adjust intensity within limits, and charge the device if it is rechargeable.
How long does the battery last?
Battery life depends on the system type and usage pattern. Rechargeable systems may last for several years and require periodic charging.
Is SCS only for back pain?
No. It is used for selected chronic pain conditions, but in the context of FBSS it is especially valuable for persistent neuropathic back and leg pain after surgery.
What if the trial does not work?
If the trial does not provide meaningful benefit, permanent implantation is usually not performed.
Can the leads move after implantation?
Yes, lead migration can happen. Proper anchoring and careful post-procedure instructions help reduce this risk.
Is infection a concern?
Yes. Infection is one of the important risks of SCS, which is why sterile technique and follow-up are very important.
Will I be able to stop all pain medicines after SCS?
Not always. Some patients reduce medication significantly, while others still need medicines, though often at a lower level.
Why SCS should be considered early in selected FBSS patients
Many patients with persistent post-surgical spine pain spend years moving from one medication to another or undergoing repeated procedures without durable benefit. In properly selected patients with predominant neuropathic pain, SCS should not be viewed as a last desperate step. It should be considered as a structured, evidence-based neuromodulation strategy when conservative treatment has clearly failed.
https://www.slideshare.net/slideshow/embed_code/key/MHaHkbALt2Dz4D
comprehensive-overview-of-spinal-cord-stimulation-for-pain-management from Daradia: The Pain Clinic
